{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T20:54:06Z","timestamp":1792011246333,"version":"4.4.0"},"update-to":[{"DOI":"10.1016\/j.ijbiomac.2025.140438","type":"retraction","label":"Retraction","source":"publisher","updated":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000}}],"reference-count":43,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100006407","name":"Natural Science Foundation of Henan Province","doi-asserted-by":"publisher","award":["2023GXNSFAA026079"],"award-info":[{"award-number":["2023GXNSFAA026079"]}],"id":[{"id":"10.13039\/501100006407","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Biological Macromolecules"],"published-print":{"date-parts":[[2025,4]]},"DOI":"10.1016\/j.ijbiomac.2025.140438","type":"journal-article","created":{"date-parts":[[2025,1,27]],"date-time":"2025-01-27T18:55:46Z","timestamp":1738004146000},"page":"140438","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["RETRACTED: Correlation between TCF7 and bladder cancer and feasibility of Erlotinib targeting in bladder cancer: Molecular mechanism and expression of TCF7 recombinant protein"],"prefix":"10.1016","volume":"301","author":[{"given":"Zengmi","family":"Mo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shasha","family":"Gai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaopeng","family":"Qin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dongdong","family":"Meng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jichao","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wentong","family":"Ya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sheng","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qun","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.ijbiomac.2025.140438_bb0005","doi-asserted-by":"crossref","first-page":"1557","DOI":"10.3390\/ijms25031557","article-title":"Mini-review: current bladder Cancer treatment\u2014the need for improvement","volume":"25","author":"Gill","year":"2024","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.ijbiomac.2025.140438_bb0010","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1016\/j.semcancer.2021.12.010","article-title":"Urinary microbiota and bladder cancer: a systematic review and a focus on uropathogens","volume":"86","author":"Yacouba","year":"2022","journal-title":"Semin. Cancer Biol."},{"key":"10.1016\/j.ijbiomac.2025.140438_bb0015","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2021.778973","article-title":"Functional nanomedicines for targeted therapy of bladder Cancer","volume":"12","author":"Tang","year":"2021","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.ijbiomac.2025.140438_bb0020","first-page":"315","article-title":"Intravesical chemotherapy synergize with an immune adjuvant by a thermo-sensitive hydrogel system for bladder cancer","volume":"31","author":"Liu","year":"2023","journal-title":"Bioact Mater."},{"key":"10.1016\/j.ijbiomac.2025.140438_bb0025","doi-asserted-by":"crossref","DOI":"10.3389\/fcell.2022.950241","article-title":"The origin and evolution of bladder Cancer stem cells","volume":"10","author":"Tan","year":"2022","journal-title":"Front. Cell Dev. Biol."},{"issue":"Pt 1","key":"10.1016\/j.ijbiomac.2025.140438_bb0030","article-title":"Expression of transferrin receptor\/TFRC protein in bladder cancer cell T24 and its role in inducing iron death in bladder cancer","volume":"274","author":"Qin","year":"2024","journal-title":"Int. J. Biol. Macromol."},{"key":"10.1016\/j.ijbiomac.2025.140438_bb0035","article-title":"Frontiers in bladder Cancer genomic research","volume":"11","author":"Li","year":"2021","journal-title":"Front. Oncol."},{"key":"10.1016\/j.ijbiomac.2025.140438_bb0040","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.canlet.2021.02.010","article-title":"Lymphatic metastasis of bladder cancer: molecular mechanisms, diagnosis and targeted therapy","volume":"505","author":"Liu","year":"2021","journal-title":"Cancer Lett."},{"key":"10.1016\/j.ijbiomac.2025.140438_bb0045","doi-asserted-by":"crossref","DOI":"10.1016\/j.bcp.2024.116111","article-title":"SRT1720 inhibits bladder cancer cell progression by impairing autophagic flux","volume":"222","author":"Li","year":"2024","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.ijbiomac.2025.140438_bb0050","doi-asserted-by":"crossref","DOI":"10.3389\/fchem.2021.765552","article-title":"Quinazoline derivatives as potential therapeutic agents in urinary bladder Cancer therapy","volume":"9","author":"Wdowiak","year":"2021","journal-title":"Front. Chem."},{"key":"10.1016\/j.ijbiomac.2025.140438_bb0055","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1186\/s12967-023-04303-3","article-title":"TGF-\u03b21 dominates stromal fibroblast-mediated EMT via the FAP\/VCAN axis in bladder cancer cells","volume":"21","author":"Ping","year":"2023","journal-title":"J. Transl. Med."},{"key":"10.1016\/j.ijbiomac.2025.140438_bb0060","doi-asserted-by":"crossref","first-page":"956","DOI":"10.1186\/s12885-023-11175-9","article-title":"MiR-205-3p suppresses bladder cancer progression via GLO1 mediated P38\/ERK activation","volume":"23","author":"Zhenhai","year":"2023","journal-title":"BMC Cancer"},{"issue":"17","key":"10.1016\/j.ijbiomac.2025.140438_bb0065","doi-asserted-by":"crossref","first-page":"3812","DOI":"10.3390\/nu15173812","article-title":"Relationship between bladder Cancer, nutritional supply, and treatment strategies: a comprehensive review","volume":"15","author":"Yang","year":"2023","journal-title":"Nutrients"},{"key":"10.1016\/j.ijbiomac.2025.140438_bb0070","article-title":"Emerging biomarkers for predicting bladder Cancer lymph node metastasis","volume":"11","author":"Zhang","year":"2021","journal-title":"Front. Oncol."},{"issue":"3","key":"10.1016\/j.ijbiomac.2025.140438_bb0075","doi-asserted-by":"crossref","first-page":"1286","DOI":"10.21037\/tau-21-81","article-title":"Comprehensive analysis of the lncRNA-miRNA-mRNA regulatory network for bladder cancer","volume":"10","author":"Huang","year":"2021","journal-title":"Transl Androl Urol."},{"issue":"4","key":"10.1016\/j.ijbiomac.2025.140438_bb0080","doi-asserted-by":"crossref","first-page":"216","DOI":"10.6004\/jnccn.2024.0024","article-title":"NCCN guidelines\u00ae insights: bladder Cancer, version 3.2024: featured updates to the NCCN guidelines","volume":"22","author":"Flaig","year":"2024","journal-title":"J. Natl. Compr. Canc. Netw."},{"issue":"10","key":"10.1016\/j.ijbiomac.2025.140438_bb0085","doi-asserted-by":"crossref","first-page":"1516","DOI":"10.1158\/1541-7786.MCR-20-1029","article-title":"TRAF4 inhibits bladder Cancer progression by promoting BMP\/SMAD signaling","volume":"20","author":"Iyengar","year":"2022","journal-title":"Mol. Cancer Res."},{"key":"10.1016\/j.ijbiomac.2025.140438_bb0090","doi-asserted-by":"crossref","unstructured":"Wang H, Mei Y, Luo C, et al. Single-Cell Analyses Reveal Mechanisms of Cancer Stem Cell Maintenance and Epithelial\u2013Mesenchymal Transition in Recurrent Bladder Cancer. Clin. Cancer Res. 2022;27(22):6265\u20136278. doi:https:\/\/doi.org\/10.1158\/1078-0432.CCR-20-4796.","DOI":"10.1158\/1078-0432.CCR-20-4796"},{"issue":"4","key":"10.1016\/j.ijbiomac.2025.140438_bb0095","doi-asserted-by":"crossref","first-page":"1389","DOI":"10.7150\/ijbs.83774","article-title":"UPP1 enhances bladder cancer progression and gemcitabine resistance through AKT","volume":"20","author":"Du","year":"2024","journal-title":"Int. J. Biol. Sci."},{"key":"10.1016\/j.ijbiomac.2025.140438_bb0100","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-022-27107-9","article-title":"CD46 protects the bladder cancer cells from cetuximab-mediated cytotoxicity","volume":"12","author":"Do","year":"2022","journal-title":"Sci. Rep."},{"issue":"5","key":"10.1016\/j.ijbiomac.2025.140438_bb0105","doi-asserted-by":"crossref","first-page":"2598","DOI":"10.1021\/acs.jmedchem.8b01927","article-title":"Epidermal growth factor receptor targeted multifunctional photosensitizers for bladder Cancer imaging and photodynamic therapy","volume":"62","author":"Cheruku","year":"2019","journal-title":"J. Med. Chem."},{"issue":"3","key":"10.1016\/j.ijbiomac.2025.140438_bb0110","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1158\/1940-6207.CAPR-19-0339","article-title":"Combination of erlotinib and naproxen employing pulsatile or intermittent dosing profoundly inhibits urinary bladder cancers","volume":"13","author":"Mohammed","year":"2019","journal-title":"Cancer Prev Res Phila Pa."},{"key":"10.1016\/j.ijbiomac.2025.140438_bb0115","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2022.849364","article-title":"Design, synthesis, and antitumor activity of Erlotinib derivatives","volume":"13","author":"Mao","year":"2022","journal-title":"Front. Pharmacol."},{"issue":"5","key":"10.1016\/j.ijbiomac.2025.140438_bb0120","doi-asserted-by":"crossref","first-page":"1171","DOI":"10.1536\/ihj.21-130","article-title":"Erlotinib-induced cardiomyopathy in a patient with metastatic non-small cell lung Cancer","volume":"62","author":"Nagashio","year":"2021","journal-title":"Int. Heart J."},{"issue":"44","key":"10.1016\/j.ijbiomac.2025.140438_bb0125","doi-asserted-by":"crossref","first-page":"6856","DOI":"10.1038\/s41388-020-01465-y","article-title":"EGFR activity addiction facilitates anti-ERBB based combination treatment of squamous bladder cancer","volume":"39","author":"Rose","year":"2020","journal-title":"Oncogene"},{"issue":"3","key":"10.1016\/j.ijbiomac.2025.140438_bb0130","first-page":"209","article-title":"Global Cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"71","author":"Sung","year":"2021","journal-title":"CA Cancer J. Clin."},{"issue":"20","key":"10.1016\/j.ijbiomac.2025.140438_bb0135","doi-asserted-by":"crossref","DOI":"10.1007\/s00432-023-05484-6","article-title":"MicroRNA-367-3p directly targets RAB23 and inhibits proliferation, migration and invasion of bladder cancer cells and increases cisplatin sensitivity","volume":"149","author":"Wei","year":"2023","journal-title":"J. Cancer Res. Clin. Oncol."},{"issue":"5","key":"10.1016\/j.ijbiomac.2025.140438_bb0140","first-page":"404","article-title":"Treatment of muscle-invasive and advanced bladder cancer in 2020","volume":"70","author":"Patel","year":"2020","journal-title":"CA Cancer J. Clin."},{"key":"10.1016\/j.ijbiomac.2025.140438_bb0145","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1186\/s12967-022-03508-2","article-title":"Bladder cancer-derived exosomal KRT6B promotes invasion and metastasis by inducing EMT and regulating the immune microenvironment","volume":"20","author":"Song","year":"2022","journal-title":"J. Transl. Med."},{"key":"10.1016\/j.ijbiomac.2025.140438_bb0150","doi-asserted-by":"crossref","DOI":"10.3389\/fgene.2022.1027909","article-title":"Single-cell sequencing technologies in bladder cancer research: applications and challenges","volume":"13","author":"Lyu","year":"2022","journal-title":"Front. Genet."},{"issue":"2","key":"10.1016\/j.ijbiomac.2025.140438_bb0155","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1038\/s41416-022-01794-7","article-title":"SBSN drives bladder cancer metastasis via EGFR\/SRC\/STAT3 signalling","volume":"127","author":"Zhou","year":"2022","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.ijbiomac.2025.140438_bb0160","doi-asserted-by":"crossref","DOI":"10.1016\/j.cellsig.2023.110893","article-title":"DUSP2 affects bladder cancer prognosis by down-regulating MEK\/ERK and P38 MAPK signaling pathways through PTPN7","volume":"112","author":"Zou","year":"2023","journal-title":"Cell. Signal."},{"issue":"9","key":"10.1016\/j.ijbiomac.2025.140438_bb0165","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1038\/s41419-024-07044-3","article-title":"SPHK1 promotes bladder cancer metastasis via PD-L2\/c-Src\/FAK signaling cascade","volume":"15","author":"Kao","year":"2024","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.ijbiomac.2025.140438_bb0170","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2023.1114203","article-title":"Identifying novel biomarkers associated with bladder cancer treatment outcomes","volume":"13","author":"Castaneda","year":"2023","journal-title":"Front. Oncol."},{"key":"10.1016\/j.ijbiomac.2025.140438_bb0175","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1186\/s12935-024-03222-7","article-title":"USP5 facilitates bladder cancer progression by stabilizing the c-Jun protein","volume":"24","author":"Zhang","year":"2024","journal-title":"Cancer Cell Int."},{"key":"10.1016\/j.ijbiomac.2025.140438_bb0180","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1186\/s12943-021-01372-0","article-title":"Circ3823 contributes to growth, metastasis and angiogenesis of colorectal cancer: involvement of miR-30c-5p\/TCF7 axis","volume":"20","author":"Guo","year":"2021","journal-title":"Mol. Cancer"},{"issue":"2","key":"10.1016\/j.ijbiomac.2025.140438_bb0185","first-page":"132","article-title":"Gene silencing of transcription factor TEAD4 inhibits esophageal cancer cells by regulating TCF7","volume":"38","author":"He","year":"2023","journal-title":"Cancer Biother. Radiopharm."},{"issue":"21","key":"10.1016\/j.ijbiomac.2025.140438_bb0190","doi-asserted-by":"crossref","DOI":"10.18632\/aging.205166","article-title":"Collaborating single-cell and bulk RNA sequencing for comprehensive characterization of the intratumor heterogeneity and prognostic model development for bladder cancer","volume":"15","author":"Wang","year":"2023","journal-title":"Aging"},{"key":"10.1016\/j.ijbiomac.2025.140438_bb0195","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/j.canlet.2021.04.028","article-title":"GABRP sustains the stemness of triple-negative breast cancer cells through EGFR signaling","volume":"514","author":"Li","year":"2021","journal-title":"Cancer Lett."},{"issue":"3","key":"10.1016\/j.ijbiomac.2025.140438_bb0200","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1038\/s41419-024-06502-2","article-title":"PDZK1 suppresses TNBC development and sensitizes TNBC cells to erlotinib via the EGFR pathway","volume":"15","author":"Ma","year":"2024","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.ijbiomac.2025.140438_bb0205","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1186\/s12943-024-01965-5","article-title":"Activation of the PI3K\/AKT signaling pathway by ARNTL2 enhances cellular glycolysis and sensitizes pancreatic adenocarcinoma to erlotinib","volume":"23","author":"Ge","year":"2024","journal-title":"Mol. Cancer"},{"issue":"19","key":"10.1016\/j.ijbiomac.2025.140438_bb0210","doi-asserted-by":"crossref","first-page":"4891","DOI":"10.3390\/cancers13194891","article-title":"Targetable pathways in advanced bladder cancer: FGFR signaling","volume":"13","author":"Xiao","year":"2021","journal-title":"Cancers"},{"issue":"2","key":"10.1016\/j.ijbiomac.2025.140438_bb0215","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1001\/jamaoncol.2015.4364","article-title":"Erlotinib and the risk of oral cancer: the erlotinib prevention of oral cancer (EPOC) randomized clinical trial","volume":"2","author":"William","year":"2016","journal-title":"JAMA Oncol."}],"updated-by":[{"DOI":"10.1016\/j.ijbiomac.2025.140438","type":"retraction","label":"Retraction","source":"publisher","updated":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000}},{"DOI":"10.1016\/j.ijbiomac.2026.153654","type":"erratum","label":"Erratum","source":"publisher","updated":{"date-parts":[[2026,7,30]],"date-time":"2026-07-30T00:00:00Z","timestamp":1785369600000}},{"DOI":"10.1016\/j.ijbiomac.2026.153654","type":"retraction","label":"Retraction","source":"retraction-watch","updated":{"date-parts":[[2026,7,30]],"date-time":"2026-07-30T00:00:00Z","timestamp":1785369600000},"record-id":"72350"},{"DOI":"10.1016\/j.ijbiomac.2026.153654","type":"erratum","label":"Erratum","source":"publisher","updated":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000}}],"container-title":["International Journal of Biological Macromolecules"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0141813025009870?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0141813025009870?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T10:13:50Z","timestamp":1782900830000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0141813025009870"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4]]},"references-count":43,"alternative-id":["S0141813025009870"],"URL":"https:\/\/doi.org\/10.1016\/j.ijbiomac.2025.140438","relation":{},"ISSN":["0141-8130"],"issn-type":[{"value":"0141-8130","type":"print"}],"subject":[],"published":{"date-parts":[[2025,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"RETRACTED: Correlation between TCF7 and bladder cancer and feasibility of Erlotinib targeting in bladder cancer: Molecular mechanism and expression of TCF7 recombinant protein","name":"articletitle","label":"Article Title"},{"value":"International Journal of Biological Macromolecules","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijbiomac.2025.140438","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"140438"}}